Anavex Life Sciences Corp (AVXL)

[Hosai]

Daniel Klamer is doing a 30 min presentation at the 4th Mitochondrial Dysfunction Drug Development Summit in Boston today with this title - "Uncovering Mitochondrial & Related Pathways for Parkinson’s Disease & Dementia to Discover Biomarkers".

Then just after he's in a 45 min fireside chat - "Adopting an Integrated Approach to Measuring Mitochondrial Activity for
Validating Biomarkers".

Yesterday was day 1 which he chaired - https://www.linkedin.com/feed/update/urn:li:activity:7265132981608955904/